{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-031569","form_type":"8-K","ticker":"PURE","cik":"0001006028","company_name":"PURE BIOSCIENCE, INC.","filed_at":"2021-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.039988+00:00","generated_at":"2026-06-28T00:45:41.027230+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PURE Bioscience Q1 revenue plunges 65% to $497k; net loss widens to $796k","bullets":["Net product sales $497k, down 65% YoY; net loss $796k vs $180k; EPS $(0.01) vs $(0.00).","Gross margin improved to 65% from 55% due to higher-margin product mix.","Hired marketing firm; interviewing for Director of Sales; negotiating Canadian distributor contract.","In-facility validation with second largest US produce processor; evaluating at 16-plant food processor chain."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-031569","json":"https://secwatch.observer/filing/0001493152-21-031569.json","markdown":"https://secwatch.observer/filing/0001493152-21-031569.md","text":"https://secwatch.observer/filing/0001493152-21-031569.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006028/000149315221031569/0001493152-21-031569-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006028/000149315221031569/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T00:45:41.027230+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}